The role of OPN in the progression of cardiovascular diseases and heart failure is undeniable, and it was demonstrated in studies utilizing OPN-null mice and experiments with its depletion by neutralizing antibodies or via targeted mutagenesis (reviewed in [163,164]). This evidence concerns the gene SPP1 and cardiovascular disorder.